Epithalon

Epithalon was developed in Russia over several decades of research on pineal gland bioregulators. The peptide is a synthetic version of the natural tetrapeptide produced by the pineal gland epithelium, and has been studied extensively in both animal models and human trials — some spanning 15+ years — making it one of the most longitudinally studied peptide bioregulators.

Its primary claim to scientific attention is the activation of telomerase reverse transcriptase (TERT), the catalytic subunit of the telomerase complex. By elongating telomeres — the protective caps on chromosomal DNA that shorten with each cell division — Epithalon may delay cellular senescence and extend healthy cell lifespan. Human trials by Khavinson et al. showed 12–16% reductions in mortality in elderly cohorts.

// TELOMERASE ACTIVATION

Epithalon upregulates expression of hTERT (human telomerase reverse transcriptase), the catalytic core of telomerase. This enables somatic cells — which normally lack active telomerase — to elongate shortened telomeres, reversing a key hallmark of cellular aging and reducing replicative senescence.

// PINEAL-MELATONIN AXIS RESTORATION

Epithalon restores age-related decline in pineal gland melatonin secretion by normalizing the activity of hydroxyindole-O-methyltransferase (HIOMT), the enzyme responsible for melatonin synthesis. Restored melatonin levels improve circadian rhythm regulation and antioxidant defense.

// ANTIOXIDANT & DNA REPAIR

Epithalon upregulates superoxide dismutase (SOD) and catalase expression, reducing oxidative stress. It also enhances DNA mismatch repair pathways, reducing mutation accumulation in aging tissues.